Table 2.
Association between pathologic features and nodal metastases
| n | Nodal metastases (%) | p value |
|
|---|---|---|---|
| Total Cohort | 145 | 7 (4.8%) | |
| Cytology | |||
| Positive | 29 | 3 (10.3%) | |
| Negative | 108 | 3 (2.8%) | .109 |
| Total* | 137 | 6 (4.4%) | |
| Peritoneum | |||
| Positive | 15 | 0 | |
| Negative | 121 | 5 (4.1%) | .552 |
| Total* | 136 | 5 (3.7%) | |
| Omentum | |||
| Positive | 5 | 0 | |
| Negative | 138 | 7 (5.1%) | .775 |
| Total* | 143 | 7 (4.9%) | |
| Fallopian Tube or Uterus | |||
| Positive | 13 | 1 (7.7%) | |
| Negative | 132 | 6 (4.5%) | .489 |
| Total | 145 | 7 (4.8%) | |
| Ovarian Surface | |||
| Positive | 34 | 4 (11.8%) | |
| Negative | 107 | 3 (2.8%) | .058 |
| Total* | 141 | 7 (5.0%) | |
| Ovarian surface/Cytology | |||
| Both positive | 8 | 3 (37.5%) | |
| All others | 125 | 3 (2.4%) | .003 |
| Total* | 133 | 6 (4.5%) | |
*
Some totals will not equal 145 as data are missing or not reported in these cases.